These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 28674307)
1. [Effects of Teicoplanin on the PT-INR Controlled by Warfarin in Infection Patients]. Nakano T; Nakamura T; Nakamura Y; Irie K; Sato K; Matsuo K; Imakyure O; Ogata K; Mishima K; Kamimura H Yakugaku Zasshi; 2017; 137(7):909-916. PubMed ID: 28674307 [TBL] [Abstract][Full Text] [Related]
2. [Effects of Tramadol Coadministration on Prothrombin Time-International Normalized Ratio in Patients Receiving Warfarin]. Hosono T; Kondo A; Kambayashi Y; Homma M Yakugaku Zasshi; 2017; 137(8):999-1003. PubMed ID: 28768953 [TBL] [Abstract][Full Text] [Related]
3. Comparison of breakthrough Gram-positive cocci infection during vancomycin vs teicoplanin therapy in patients receiving haematopoietic stem cell transplantation. Ohata K; Kitagawa J; Niwa T; Takahashi-Yamauchi T; Harada S; Matsumoto T; Nakamura N; Nakamura H; Kanemura N; Shimizu M; Suzuki A J Clin Pharm Ther; 2020 Dec; 45(6):1342-1348. PubMed ID: 32656902 [TBL] [Abstract][Full Text] [Related]
4. [Specific variability of teicoplanin protein binding in patients receiving continuous hemodiafiltration-comparison with hypoalbuminemia patients]. Yanagimoto H; Teramatsu T; Goto J; Yanagisawa M; Harii N; Suzuki M; Hanawa T; Matsuda K; Oguchi T Yakugaku Zasshi; 2013; 133(6):711-7. PubMed ID: 23558910 [TBL] [Abstract][Full Text] [Related]
5. [Combined effect of vancomycin or teicoplanin plus a beta-lactam antibiotic in mouse infection models caused by beta-lactam antibiotec-induced vancomycin resistant MRSA (BIVR)]. Hatano K; Yokota Y; Hanaki H; Sunakawa K Kansenshogaku Zasshi; 2006 May; 80(3):243-50. PubMed ID: 16780131 [TBL] [Abstract][Full Text] [Related]
6. In vitro combined effects of cefozopran/teicoplanin and cefozopran/vancomycin on methicillin-resistant Staphylococcus aureus. Toyokawa M; Asari S; Nishi I; Horikawa M; Tsukamoto H; Sunada A; Ueda A; Iwatani Y J Chemother; 2003 Feb; 15(1):31-6. PubMed ID: 12678411 [TBL] [Abstract][Full Text] [Related]
7. Changes in the pharmacokinetics of teicoplanin in patients with hyperglycaemic hypoalbuminaemia: Impact of albumin glycosylation on the binding of teicoplanin to albumin. Enokiya T; Muraki Y; Iwamoto T; Okuda M Int J Antimicrob Agents; 2015 Aug; 46(2):164-8. PubMed ID: 25982916 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the anticoagulant effect and timing of the concomitant use of S-1 and warfarin. Suzuki S; Ikegawa K; Yamamoto K; Saito S J Int Med Res; 2016 Oct; 44(5):1123-1130. PubMed ID: 27553806 [TBL] [Abstract][Full Text] [Related]
9. Improvement of Predictivity of Teicoplanin Serum Trough Concentrations at Steady State Calculated by Vancomycin Pharmacokinetic Parameter. Kobayashi R; Otomo S; Shiba Y; Ebinuma K; Sudoh T Yakugaku Zasshi; 2016; 136(11):1557-1562. PubMed ID: 27803487 [TBL] [Abstract][Full Text] [Related]
10. Incidence of acute kidney injury after teicoplanin- or vancomycin- and piperacillin/tazobactam combination therapy: A comparative study using propensity score matching analysis. Sazanami K; Inose R; Yagi T; Dote S; Horiuchi N; Kobayashi Y; Muraki Y J Infect Chemother; 2021 Dec; 27(12):1723-1728. PubMed ID: 34446352 [TBL] [Abstract][Full Text] [Related]
11. Changes in Pharmacodynamic Parameters during Co-administration of 5-FU with Warfarin: A Retrospective Case Series. Tayag JCS; Ishii T; Kokuba S; Hirata T; Shiohira H; Nakamura K Biol Pharm Bull; 2022; 45(8):1101-1105. PubMed ID: 35908892 [TBL] [Abstract][Full Text] [Related]
12. [Evaluation of Drug Interaction between S-1 and Warfarin]. Yamamoto K; Suzuki S; Ikegawa K; Nomura H; Fuse N; Saito S Gan To Kagaku Ryoho; 2016 Jan; 43(1):65-8. PubMed ID: 26809527 [TBL] [Abstract][Full Text] [Related]
14. Change of teicoplanin loading dose requirement for incremental increases of systemic inflammatory response syndrome score in the setting of sepsis. Nakano T; Nakamura Y; Takata T; Irie K; Sano K; Imakyure O; Mishima K; Futagami K Int J Clin Pharm; 2016 Aug; 38(4):908-14. PubMed ID: 27125378 [TBL] [Abstract][Full Text] [Related]
15. [Effects of Seven Tyrosine Kinase Inhibitors on the Anticoagulation Activity of Warfarin]. Hiraide M; Minowa Y; Nakano Y; Suzuki K; Shiga T; Miyoshi J; Takahashi H; Hama T Gan To Kagaku Ryoho; 2019 Nov; 46(11):1733-1739. PubMed ID: 31748483 [TBL] [Abstract][Full Text] [Related]
16. [Effects of Tyrosine Kinase Inhibitors on Control of PT-INR in Patients Receiving Warfarin]. Hiraide M; Minowa Y; Nakano Y; Yoshioka H; Suzuki K; Shiga T; Takahashi H; Hama T Gan To Kagaku Ryoho; 2019 Sep; 46(9):1413-1419. PubMed ID: 31530781 [TBL] [Abstract][Full Text] [Related]
17. [Combination effect of arbekacin and cefepime on mixed culture of MRSA and P. aeruginosa]. Araake M; Hara T; Miyata A; Tani M; Ogawa H Jpn J Antibiot; 2001 Feb; 54(2):69-78. PubMed ID: 11338680 [TBL] [Abstract][Full Text] [Related]
18. Development of a teicoplanin loading regimen that rapidly achieves target serum concentrations in critically ill patients with severe infections. Nakamura A; Takasu O; Sakai Y; Sakamoto T; Yamashita N; Mori S; Morita T; Nabeta M; Hirayu N; Yoshiyama N; Moroki M; Tashiro K; Kannae M J Infect Chemother; 2015 Jun; 21(6):449-55. PubMed ID: 25726436 [TBL] [Abstract][Full Text] [Related]
19. D-Dimer versus International Normalized Ratio of Prothrombin Time in Ischemic Stroke Patients Treated with Sufficient Warfarin. Yamamoto R; Nakae Y; Tanaka F; Johkura K J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1781-1785. PubMed ID: 27103270 [TBL] [Abstract][Full Text] [Related]
20. In vitro protein binding of teicoplanin to neonatal serum. Sando M; Sato Y; Iwata S; Akita H; Sunakawa K J Infect Chemother; 2004 Oct; 10(5):280-3. PubMed ID: 16163462 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]